Semaglutide in pill form for type 2 diabetes was first approved by the FDA in 2019 as Rybelsus (semaglutide) tablets 3 mg, 7 mg, and 14 mg
Those who have suffered from certain severe gastrointestinal events as a result of taking Ozempic may be able to file a personal injury lawsuit against the manufacturing company for their losses
Semaglutide is a GLP-1 receptor agonist, while Tirzepatide targets both GLP-1 and GIP pathways, offering slightly faster weight loss for some patients
Patients should be educated about potential symptoms of thyroid tumors, including persistent hoarseness, difficulty swallowing, or a neck mass, though these symptoms are rare and may have many other causes
Wegovy is the second most used weight loss injection in the UK , and it has become more widely available as costs for weight loss medications have changed